精神分裂症患者广泛白质微结构差异:ENIGMA联盟DTI工作组4322人研究
该研究整合29项国际独立研究的扩散张量成像数据,比较1963例精神分裂症患者与2359名健康对照的白质微结构。患者在白质骨架25个感兴趣区中的20个显示各向异性分数(FA)显著降低,效应量最大区域为前放射冠和胼胝体,且FA效应大于弥散率指标。
要点
- 精神分裂症患者白质FA降低广泛存在,25个感兴趣区中20个显著。
- 效应量最大区域为前放射冠(d=0.40)和胼胝体(d=0.39)。
- 未检测到发病年龄或药物剂量对白质差异的显著影响。
核心结论
- 精神分裂症患者存在广泛的白质微结构异常,以FA降低为主要表现。
研究设计与样本
- 整合29项国际独立研究的扩散张量成像数据,统一处理与统计分析后跨研究荟萃分析。
- 样本包括1963例精神分裂症患者和2359名健康对照。
主要发现
- 患者在白质骨架25个感兴趣区中的20个显示FA显著降低。
- 整个白质骨架效应量峰值d=0.42,更多由周边区域而非核心白质驱动。
- 前放射冠d=0.40,胼胝体d=0.39,其中胼胝体体部d=0.39、膝部d=0.37。
- FA效应量大于弥散率指标,患者平均弥散率和径向弥散率显著高于对照。
- 未检测到发病年龄或药物剂量对白质差异的显著效应。
临床怎么用
- FA降低可作为精神分裂症广泛白质微结构异常的候选影像标记,但尚不能用于个体诊断。
- 前放射冠和胼胝体是白质改变最显著的区域,可作为未来研究重点关注的兴趣区。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The regional distribution of white matter (WM) abnormalities in schizophrenia remains poorly understood, and reported disease effects on the brain vary widely between studies. In an effort to identify commonalities across studies, we perform what we believe is the first ever large-scale coordinated study of WM microstructural differences in schizophrenia. Our analysis consisted of 2359 healthy controls and 1963 schizophrenia patients from 29 independent international studies; we harmonized the processing and statistical analyses of diffusion tensor imaging (DTI) data across sites and meta-analyzed effects across studies. Significant reductions in fractional anisotropy (FA) in schizophrenia patients were widespread, and detected in 20 of 25 regions of interest within a WM skeleton representing all major WM fasciculi. Effect sizes varied by region, peaking at (d=0.42) for the entire WM skeleton, driven more by peripheral areas as opposed to the core WM where regions of interest were defined. The anterior corona radiata (d=0.40) and corpus callosum (d=0.39), specifically its body (d=0.39) and genu (d=0.37), showed greatest effects. Significant decreases, to lesser degrees, were observed in almost all regions analyzed. Larger effect sizes were observed for FA than diffusivity measures; significantly higher mean and radial diffusivity was observed for schizophrenia patients compared with controls. No significant effects of age at onset of schizophrenia or medication dosage were detected. As the largest coordinated analysis of WM differences in a psychiatric disorder to date, the present study provides a robust profile of widespread WM abnormalities in schizophrenia patients worldwide. Interactive three-dimensional visualization of the results is available at www.enigma-viewer.org.
引用
- Kelly S, Jahanshad N, Zalesky A, et al. Widespread white matter microstructural differences in schizophrenia across 4322 individuals: results from the ENIGMA Schizophrenia DTI Working Group. Mol Psychiatry. 2017. PMID: 29038599. doi:10.1038/mp.2017.170
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。